Maia Biotechnology CEO Vlad Vitoc buys $100,010 in company stock
On September 14, 2026, Maia Biotechnology CEO Vlad Vitoc made a significant move in his personal investment portfolio. The CEO, who owns 10% of the company, purchased 73,000 shares of common stock at a price of $1.37 per share, amounting to $100,010. This brought Mr. Vitoc's total direct ownership to 1,049,121 shares, with an additional 210,100 shares beneficially owned by his spouse.
The purchase comes after MAIA's stock price has risen 6% to $1.39 over the past week. Despite the stock being deemed overvalued by InvestingPro analysis, the company's balance sheet remains strong, with more cash than debt. However, the company faces profitability challenges, according to Six InvestingPro Tips available to subscribers.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
